Literature DB >> 323017

Viral antibodies in the sera from patients with Parkinson disease.

R J Marttila, P Arstila, J Nikoskelainen, P E Halonen, U K Rinne.   

Abstract

An assay of antibodies to 15 various viruses and mycoplasma pneumoniae was performed on the serum specimens from 441 patients with Parkinson disease and from 443 healthy controls matched by sex, age, and place of residence, or from a representative group of these matched pairs. The main finding was a higher herpes simplex complement-fixing antibody level in patients with Parkinson disease than in controls. Patients with Parkinson disease had higher herpes simplex antibody titers more often than did their matched controls, and the matched controls, respectively, had low titers more often than the patients. The mean herpes simplex antibody titer (log2) of the patients (4.9) was significantly higher than that of controls (4.6) (p less than 0.01). This difference was also demonstrable when matched pairs were analysed for paired differences of herpes simplex antibody titers. For other viral CF and HI antibodies studied and for mycoplasma pneumoniae CF antibody, there were no significant differences either in the mean titers or in the distribution of individual titer values between the patients with Parkinson disease and the matched controls.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 323017     DOI: 10.1159/000114785

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  15 in total

Review 1.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

Review 2.  The relationship between encephalitis lethargica and influenza: a critical analysis.

Authors:  Sherman McCall; Joel A Vilensky; Sid Gilman; Jeffery K Taubenberger
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

Review 3.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 4.  Evidence for association between hepatitis C virus and Parkinson's disease.

Authors:  Abdelrahman Ibrahim Abushouk; Mostafa Wanees Ahmed El-Husseny; Mayar Magdy; Ammar Ismail; Attia Attia; Hussien Ahmed; Ravikishore Pallanti; Ahmed Negida
Journal:  Neurol Sci       Date:  2017-08-05       Impact factor: 3.307

5.  Viruses, Parkinsonism and Alzheimer's disease.

Authors:  D M Mann; P O Yates; J S Davies; J Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-07       Impact factor: 10.154

6.  Epidemiology of Parkinson's disease--an overview.

Authors:  R J Marttila; U K Rinne
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study.

Authors:  J P Hubble; T Cao; J A Kjelstrom; W C Koller; B L Beaman
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Antibodies to Epstein-Barr virus, herpes simplex type 1, cytomegalovirus and measles virus in psychiatric patients.

Authors:  T Gotlieb-Stematsky; J Zonis; A Arlazoroff; T Mozes; M Sigal; A G Szekely
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 9.  Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria.

Authors:  Judith Miklossy
Journal:  J Neuroinflammation       Date:  2011-08-04       Impact factor: 8.322

Review 10.  A role for viral infections in Parkinson's etiology?

Authors:  Laura K Olsen; Eilis Dowd; Declan P McKernan
Journal:  Neuronal Signal       Date:  2018-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.